XRN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.881600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.190600E-01
Normal-vs-Stage2
3.937200E-01
Normal-vs-Stage3
7.019600E-01
Normal-vs-Stage4
7.578200E-01
Stage1-vs-Stage2
9.945000E-01
Stage1-vs-Stage3
9.914800E-01
Stage1-vs-Stage4
7.252800E-01
Stage2-vs-Stage3
9.933200E-01
Stage2-vs-Stage4
6.640200E-01
Stage3-vs-Stage4
8.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.625400E-01
Normal-vs-AfricanAmerican
9.773400E-01
Normal-vs-Asian
3.080400E-01
Caucasian-vs-AfricanAmerican
1.882030E-01
Caucasian-vs-Asian
7.845000E-01
AfricanAmerican-vs-Asian
2.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.587400E-01
Normal-vs-Female
4.485600E-01
Male-vs-Female
4.734800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.446600E-01
Normal-vs-Age(41-60Yrs)
8.612600E-01
Normal-vs-Age(61-80Yrs)
2.279200E-01
Normal-vs-Age(81-100Yrs)
3.500400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.136800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.648600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.266200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.816500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.434220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.488800E-01
Normal-vs-Daily Drinker
8.626200E-02
Normal-vs-Weekly Drinker
4.750400E-01
Normal-vs-Occasional Drinker
5.767400E-01
Normal-vs-Social Drinker
5.075600E-01
Non Drinker-vs-Daily Drinker
1.136800E-01
Non Drinker-vs-Weekly Drinker
9.803600E-01
Non Drinker-vs-Occasional Drinker
3.862800E-01
Non Drinker-vs-Social Drinker
7.751000E-01
Daily Drinker-vs-Weekly Drinker
2.513400E-01
Daily Drinker-vs-Occasional Drinker
2.241700E-02
Daily Drinker-vs-Social Drinker
1.245760E-01
Weekly Drinker-vs-Occasional Drinker
5.057600E-01
Weekly Drinker-vs-Social Drinker
8.187800E-01
Occasional Drinker-vs-Social Drinker
6.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.797000E-01
Normal-vs-Grade 2
9.689600E-01
Normal-vs-Grade 3
9.283000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.290200E-01
Grade 1-vs-Grade 3
1.231430E-01
Grade 1-vs-Grade 4
9.797000E-01
Grade 2-vs-Grade 3
3.496000E-01
Grade 2-vs-Grade 4
9.689600E-01
Grade 3-vs-Grade 4
9.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.037200E-01
Normal-vs-NonDiabetic
3.301200E-01
Diabetic-vs-NonDiabetic
4.250600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.152000E-01
Normal-vs-NoPancreatitis
3.386000E-01
Pancreatitis-vs-NoPancreatitis
5.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.753600E-01
Normal-vs-N1
3.784800E-01
N0-vs-N1
6.532200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.135200E-01
Normal-vs-TP53-NonMutant
4.328000E-01
TP53-Mutant-vs-TP53-NonMutant
1.895410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
